Pappadopulos Elizabeth, Jensen Peter S, Chait Alanna R, Arnold L Eugene, Swanson James M, Greenhill Laurence L, Hechtman Lily, Chuang Shirley, Wells Karen C, Pelham William, Cooper Thomas, Elliott Glenn, Newcorn Jeffrey H
J Am Acad Child Adolesc Psychiatry. 2009 May;48(5):501-510. doi: 10.1097/CHI.0b013e31819c23ed.
Although research supports the use of appropriately administered stimulant medication to treat children with ADHD, poor adherence and early termination undermine the efficacy of this treatment in real-world settings. Moreover, adherence measures often rely on parent report of medication use, and their validity and reliability are unknown.
Drawing on data from 254 participants in the NIMH Collaborative Multisite Multimodal Treatment Study of Children With Attention-Deficit/Hyperactivity Disorder, we examine the discrepancy between parents' verbal reports of medication adherence and physiological adherence measures determined via methylphenidate saliva assays collected at four time points during the 14-month treatment period. In addition, we examine the impact of physiologically documented medication adherence on parent- and teacher-reported outcomes through 14 months.
Overall, nearly one fourth (24.5%) of the saliva samples indicated nonadherence. Among subjects, 63 (24.8%) of the 254 participants were nonadherent on 50% or more of their repeated saliva assays. Only 136 (53.5%) of the subjects were adherent at every time point at which saliva assays were taken, indicating that some degree of nonadherence characterized nearly half of all other NIMH Collaborative Multisite Multimodal Treatment Study of Children With Attention-Deficit/Hyperactivity Disorder-treated children. Findings also indicated that nonadherence produced greater deleterious effects in children in the medication-only condition compared with those receiving both medication and behavioral treatment.
Same-day saliva methylphenidate assays suggest that nearly half of the parents are inaccurate informants of their child's ADHD medication adherence and that parents may overestimate actual (physiological) adherence. This finding suggests the need for interventions to improve accuracy of parental report. Clinicians need to focus on adherence enhancement strategies to improve outcomes of children being treated with medication, particularly when benefits are suboptimal.
尽管研究支持使用适当管理的兴奋剂药物来治疗患有注意力缺陷多动障碍(ADHD)的儿童,但依从性差和早期停药会削弱这种治疗在现实环境中的疗效。此外,依从性测量通常依赖于家长对药物使用情况的报告,但其有效性和可靠性尚不清楚。
利用美国国立精神卫生研究所(NIMH)注意力缺陷/多动障碍儿童协作多地点多模式治疗研究中254名参与者的数据,我们研究了家长对药物依从性的口头报告与在14个月治疗期内四个时间点收集的哌甲酯唾液检测所确定的生理依从性测量之间的差异。此外,我们通过14个月的时间研究了生理记录的药物依从性对家长和教师报告结果的影响。
总体而言,近四分之一(24.5%)的唾液样本显示未依从。在这些受试者中,254名参与者中有63名(24.8%)在50%或更多的重复唾液检测中未依从。只有136名(53.5%)受试者在每次进行唾液检测时都依从,这表明在所有其他接受NIMH注意力缺陷/多动障碍儿童协作多地点多模式治疗研究治疗的儿童中,近一半存在某种程度的不依从。研究结果还表明,与接受药物和行为治疗的儿童相比,仅接受药物治疗的儿童中,不依从产生的有害影响更大。
同日哌甲酯唾液检测表明,近一半的家长对其孩子ADHD药物依从性的报告不准确,家长可能高估了实际(生理)依从性。这一发现表明需要采取干预措施来提高家长报告的准确性。临床医生需要专注于增强依从性的策略,以改善接受药物治疗儿童的治疗效果,特别是当益处不理想时。